Article Text

Download PDFPDF
Salbutamol in paediatrics: pharmacology, prescribing and controversies
  1. Paul Andrzejowski1,
  2. Will Carroll2
  1. 1Sheffield Hand Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Northern General Hospital, Sheffield, South Yorkshire, UK
  2. 2Department of Respiratory Paediatrics, University Hospitals of North Midlands, Staffordshire, UK
  1. Correspondence to Dr Will Carroll, University Hospital of North Midlands, Newcastle Road, Stoke-on-Trent ST4 6QG, UK; will.carroll{at}


Salbutamol has become a key drug in respiratory medicine since it was first developed by Sir David Jack et al in 1968, 5000 years after the β agonist ephedrine was first used in its raw form, as the Ma Huang herb in Chinese medicine to treat asthma. It is one of the most commonly encountered medicines in paediatric practice and the authors have found that an understanding of its pharmacology in clinical practice is incredibly helpful. In this article, we discuss its pharmacology and pharmacodynamics, practical prescribing points and some unresolved issues surrounding its use, which should serve to provide an essential working knowledge for the busy paediatrician.

  • Respiratory
  • General Paediatrics
  • Pharmacology
  • Accident & Emergency
  • Genetics

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.